News wire

Drugs and medical devices

Pharmaceuticals, implants and medical devices: safety communications, label changes, approvals and the litigation that follows them.

Source check 14 min ago · Newest item 10 hr ago · 1,441 stories this week · 85 of 90 publishers answering · Browse publishers · RSS feed

PI DATA HUBLegal intelligence
Filter stories (1)

Drugs and medical devices

Friday, October 2

Thursday, October 1

Wednesday, September 30

Federal Register notice Federal Register: FDA

Medical Devices; Gastroenterology-Urology Devices; Classification of the Flushing and Storage Solution for Vascular Autografts at Room Temperature

The Food and Drug Administration (FDA) is classifying the flushing and storage solution for vascular autografts at room temperature into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the flushing and storage solution for vascular autografts at room temperature. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of the safety and effectiveness of the device. We believe this action will also…

Read at Federal Register: FDA

Tuesday, September 29

Friday, September 25

Thursday, September 24

Wednesday, September 23

Monday, September 21

Saturday, September 19

Friday, September 18

Thursday, September 17

Tuesday, September 15

Friday, September 11

Federal Register notice Federal Register: FDA

Medical Devices; Cardiovascular Devices; Classification of the Cardiovascular Machine Learning-Based Notification Software

The Food and Drug Administration (FDA) is classifying the cardiovascular machine learning-based notification software into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the cardiovascular machine learning- based notification software. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of the safety and effectiveness of the device. We believe this action will also enhance patients' access…

Read at Federal Register: FDA

Connect the news to your market.

Research the firms, offices and conference relationships behind the headlines.

Request research access